A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity data. (2019)
Attributed to:
Adaptive Clinical Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/rssc.12323
PubMed Identifier: 30880843
Publication URI: http://europepmc.org/abstract/MED/30880843
Type: Journal Article/Review
Volume: 68
Parent Publication: Journal of the Royal Statistical Society. Series C, Applied statistics
Issue: 2
ISSN: 0035-9254